-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Professor Chen Shunle, one of the founders of rheumatology in China and known internationally as "the father of lupus in China", died at 0:30 on the 23rd at the age of 89.
In the motherland medicine, systemic lupus erythematosus (SLE) is called "butterfly disease", Professor Chen Shunle hoped that his patients, like a beautiful butterfly, break free of the shackles of disease, in their own lives to fly.
Professor Chen Shunle, born in February 1932, is the founder of the rheumatology department of Renji Hospital, affiliated with Shanghai Jiaoxuan University School of Medicine, and the Shanghai Institute of Rheumatology, which has presided over the establishment of China's largest genetic database of the core family of lupus, and the creation of a combination of immunosuppressants to improve efficacy while reducing side effects.
he was awarded the Master of the American Rheumatology Institute and the Asia Pacific Rheumatology Alliance Master Award.
Huangpu River, 145 Zhonglu, Shandong Province, now Renji Hospital West Hospital has a brick-red building that has experienced more than 80 years of wind and rain, where Chen Shunle has worked for half a century.
Chen Shunle chose systemic lupus erythematosus (SLE) as the main direction of rheumatism.
is an autoimmune disease that can affect multiple organs throughout the body, with complex lesions, difficulty in treatment, and extremely high mortality rates.
, there was no epidemiological investigation of SLE incidence in China.
is widely believed Chinese the prevalence of lupus in the united States is high and serious.
Established a laboratory testing platform for autoimmune diseases, and through independent research and development, established relevant testing technology in China, so that the diagnosis of SLE can be based on.
then, he conducted a large-scale epidemiological survey of 32,668 Textile Workers in Shanghai and found that the prevalence rate of SLE in China was 70 per 100,000 and 113 per 100,000 in women.
results were written into chinese medical students' textbooks and caught the world's eye.
in the treatment, Chen Shunle found that although high-dose hormones are beneficial to control the disease, but bring many side effects, drug-induced complications greatly affect the quality of life of patients.
his innovative treatments, which became a classic treatment for SLE patients, greatly improving survival rates and allowing many patients to live and work normally.
Chen Shunle held several national courses to promote the laboratory diagnosis technology of rheumatism and improve the level of diagnosis of rheumatism in China.
In 1988, he formulated the diagnostic standard of SLE in China, which was verified by the relevant departments of 27 medical units in China, and confirmed that it was more beneficial to the early diagnosis of SLE than the ARA standard in 1982, and was adopted as a national standard and included in the textbooks of medical colleges and universities.
1990s, when molecular genetics research was just making waves internationally, Professor Chen Shunle's research team became the first in China to engage in rheumatology genetics research.
Gynecology, Radiology, Orthopedics, Pediatrics, Endocrinology and Cardiology are the most closely linked departments in rheumatology, and Chen Shunle has formed the GROPEC Partnership, which hopes to promote the development of rheumatology and the development of various disciplines through interdisciplinary collaboration.
it is understood that in the past lupus treatment process, pregnancy is considered to aggravate the disease, doctors generally do not recommend the patient to give birth, which increases the psychological burden and pain of patients.
rheumatology and obstetrics and gynecology, after continuous attempts and efforts, finally achieved a breakthrough of zero: in 1992, the first SLE patient's baby fell to the ground.
, SLE is no longer a no-go zone for fertility.
Chen Shunle also summarized and put forward the pre-pregnancy disease relief standards for SLE patients to provide reference for clinicians' treatment decisions.
, a discipline leader in the rheumatology department of the PLA General Hospital, was a participant in the 1991 Shanghai International Rheumatology New Progress Course organized by Chen Shunle and WHO.
In an interview, he said: "Professor Chen not only high house building in his own department to carry out cutting-edge research in line with international standards, but also for the national popularization of basic and clinical immunology, clinical rheumatology knowledge to work hard ... It opens the window to the world of rheumatology abroad and builds a platform for the younger generation of rheumatology scholars in our country to connect with the world.
" not only let patients have the same life as healthy people, but also let them have the ability to be beautiful and participate in social competition, which is Chen Shunle's dream.
at the beginning of his career, he proposed the establishment of a standardized and sustainable database of rheumatology patients.
from the original hand-drawn follow-up table to the present electronic database; A single document documents each onset and remission of the patient, and a chart reveals the pathogenesis and pathogenesis of the disease.
it is learned that on the occasion of the 50th anniversary of Professor Chen Shunle's medical treatment, Zhong Nanshan, a member of the Chinese Academy of Engineering, waved his words:
Qingyun dressed in white neon, shot Sirius with a long target."
" Chen Jing Source: China News Network Copyright Notice: All text, images and audio and video materials on this website that indicate "Source: Met Medical" or "Source: MedSci Original" are owned by Metz Medical and may not be reproduced by any media, website or individual without authorization, and shall be reproduced with the words "Source: Mets Medicine".
all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
at the same time reproduced content does not represent the position of this site.
leave a message here